ConductScience.org, home

Paper42569744

Evaluation of salivary vimentin in oral erosive lichen planus, oral leukoplakia, oral squamous cell carcinoma and healthy subjects using ELISA.

Arjun O and 2 others. J Oral Maxillofac Pathol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of salivary vimentin in oral erosive lichen planus, oral leukoplakia, oral squamous cell carcinoma and healthy subjects using ELISA. Papers, record 42569744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42569744

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of salivary vimentin in oral erosive lichen planus, oral leukoplakia, oral squamous cell carcinoma and healthy subjects using ELISA.
PubMed
Journal
J Oral Maxillofac Pathol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arjun OO
2Rathy RR
3Neena AA

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127162585Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx.Oman Med J2016https://conductscience.org/library/papers/27162585PubMed
235207438Biomarker Potential of Vimentin in Oral Cancers.Life (Basel)2022https://conductscience.org/library/papers/35207438PubMed
3280847Definition of leukoplakia and related lesions: an aid to studies on oral precancer.Oral Surg Oral Med Oral Pathol1978https://conductscience.org/library/papers/280847PubMed
436213468Role of Vimentin and E-cadherin Expression in Premalignant and Malignant Lesions of Oral Cavity.Indian J Otolaryngol Head Neck Surg2022https://conductscience.org/library/papers/36213468PubMed
526045832Expression of E-cadherin and vimentin in oral squamous cell carcinoma.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26045832PubMed
635968190Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma - An immunohistochemical study.J Oral Maxillofac Pathol2022https://conductscience.org/library/papers/35968190PubMed
730189187Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation.Exp Mol Pathol2018https://conductscience.org/library/papers/30189187PubMed
8354985352D-DIGE-Based Proteomic Profiling with Validations Identifies Vimentin as a Secretory Biomarker Useful for Early Detection and Poor Prognosis in Oral Cancers.J Oncol2022https://conductscience.org/library/papers/35498535PubMed
98056441Risk assessment of tobacco, alcohol and diet in oral cancer--a case-control study.Int J Cancer1994https://conductscience.org/library/papers/8056441PubMed
1010922335Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India.Int J Epidemiol2000https://conductscience.org/library/papers/10922335PubMed
1137445290Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia.J Clin Med2023https://conductscience.org/library/papers/37445290PubMed
1222991586Oral lichen planus: clinical features, etiology, treatment and management; a review of literature.J Dent Res Dent Clin Dent Prospects2010https://conductscience.org/library/papers/22991586PubMed
1323244115Risk factors for oral cancer in northeast Thailand.Asian Pac J Cancer Prev2012https://conductscience.org/library/papers/23244115PubMed
1439198076Malignant transformation rate of erosive oral lichen planus: a retrospective study.Br J Oral Maxillofac Surg2024https://conductscience.org/library/papers/39198076PubMed
1521637948Vimentin in cancer and its potential as a molecular target for cancer therapy.Cell Mol Life Sci2011https://conductscience.org/library/papers/21637948PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VIM7431PubTator's text mininghttps://conductscience.org/library/genes/7431

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42569744

GET https://conductscience.org/api/papers/v1/42569744/authors